Business Description
Sigma Healthcare Ltd
ISIN : AU000000SIG5
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.61 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 2.57 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.65 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.3 | |||||
3-Year EBITDA Growth Rate | -17 | |||||
3-Year EPS without NRI Growth Rate | -52.8 | |||||
3-Year Book Growth Rate | 3 | |||||
Future 3-5Y Total Revenue Growth Rate | 23.96 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -30.43 | |||||
12-1 Month Momentum % | -30.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.46 | |||||
Quick Ratio | 1.86 | |||||
Cash Ratio | 0.96 | |||||
Days Inventory | 31.46 | |||||
Days Sales Outstanding | 34.65 | |||||
Days Payable | 41.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.3 | |||||
Shareholder Yield % | -15.82 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.05 | |||||
Operating Margin % | -0.54 | |||||
Net Margin % | 0.13 | |||||
FCF Margin % | 1.09 | |||||
ROE % | 0.74 | |||||
ROA % | 0.37 | |||||
ROIC % | -1.6 | |||||
ROC (Joel Greenblatt) % | 5.06 | |||||
ROCE % | 3.11 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 253 | |||||
Forward PE Ratio | 74.63 | |||||
PE Ratio without NRI | 253 | |||||
Shiller PE Ratio | 39.1 | |||||
Price-to-Owner-Earnings | 632.5 | |||||
PS Ratio | 0.38 | |||||
PB Ratio | 2.37 | |||||
Price-to-Tangible-Book | 2.67 | |||||
Price-to-Free-Cash-Flow | 35.14 | |||||
Price-to-Operating-Cash-Flow | 30.85 | |||||
EV-to-EBIT | 73.99 | |||||
EV-to-Forward-EBIT | 17.66 | |||||
EV-to-EBITDA | 34.64 | |||||
EV-to-Forward-EBITDA | 11.44 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-Forward-Revenue | 0.25 | |||||
EV-to-FCF | 49.52 | |||||
Price-to-Projected-FCF | 1.6 | |||||
Price-to-Median-PS-Value | 2 | |||||
Price-to-Graham-Number | 5.71 | |||||
Price-to-Net-Current-Asset-Value | 5 | |||||
Earnings Yield (Greenblatt) % | 1.35 | |||||
FCF Yield % | 1.8 | |||||
Forward Rate of Return (Yacktman) % | -1.44 |